Precision Business Insights
Portfolio

 

Research Reports

Kidney Transplant Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Kidney Transplant Market by Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End-User (Hospitals, Clinics, Research Institutes), and Geography.

 

Market Outline: Kidney Transplant Market

 

Kidney transplant or renal transplant is transplantation of kidney to the end-stage renal disease (ESRD). Based on the donor kidney transplantation is classified into deceased donor or living donor transplantation. Kidney transplant gained widespread popularity by improving outcome of ESRD patients.

 

Market Dynamics: Kidney Transplant Market

Kidney transplant market is witnessed to grow at a significant CAGR owing to advancements in the kidney transplantation methods and increase in success rate of kidney transplants. Moreover, rise in prevalence of end stage renal disease (ESRD), increase in the number of deceased kidney donors, and sophisticated healthcare infrastructure are anticipated to fuel the kidney transplant market over the forecast years. However, high cost of kidney transplant procedure and adverse effects associated with organ transplantation are expected to restrain the growth of kidney transplant market.

 

Global kidney transplant market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Scope: Kidney Transplant Market

 

Global Kidney transplant market is segmented on the basis of immunosuppressive/rejection drugs and distribution channel

 

Based on the immunosuppressive/rejection drugs the market is segmented into the following:

  • Prograf (Tacrolimus)
  • Myfortic (Mycophenolic Acid)
  • Cellcept (Mycophenolate Mofetil)
  • Zortress / Certican (Everolimus)
  • Rapamune (Sirolimus)
  • Neoral / Sandimmune (Cyclosporine)

 

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores

 

Regional Analysis:  Kidney Transplant Market

 

Geographically, global kidney transplant market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America kidney transplant market is expected to expand at significant CAGR due to increase in prevalence of ESRD, rise in healthcare expenditure, and well established healthcare infrastructure. Europe kidney transplant market is anticipated to increase revenue share owing to increase in awareness about organ donation, favorable reimbursement policies for organ transplantation, and adoption of newer organ transplantation procedures. Asia pacific kidney transplant market is projected to provide enormous growth opportunities to the market players. Increased medical tourism in Asia Pacific countries, large patient pool, and government programs to enhance awareness about the organ donations are expected to bolster the market over the forecast years.

 

Competition Assessment:

  • Veloxis Pharmaceuticals A/S (Denmark)
  • Sanofi (France)
  • Immucor, Inc. (U.S)
  • Biocon Ltd. (India)
  • Novartis AG (Switzerland)
  • Pfizer, Inc. (U.S.)
  • Astellas Pharma (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)

 

Notable Market Developments:

  • In April 2017, Sanofi received FDA approval of Thymoglobulin used in preventiuon of acute kidney transplant rejection

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Table of Content
1. Executive Summary
2. Global Kidney Transplant Market Introduction
2.1. Global Kidney Transplant Market – Taxonomy
2.2. Global Kidney Transplant Market –Definitions
2.2.1. Immunosuppressive/rejection Drugs
2.2.2. Distribution Channel
3. Global Kidney Transplant Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Kidney Transplant Market Dynamic Factors – Impact Analysis
3.6. Global Kidney Transplant Market – Competition Landscape
3.7. Epidemiology
4. Global Kidney Transplant Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market OpportunityAnalysis
5. Global Kidney Transplant Market, By Immunosuppressive/rejection Drugs, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Prograf (Tacrolimus)
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Myfortic (Mycophenolic Acid)
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Cellcept (Mycophenolate Mofetil)
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Zortress / Certican (Everolimus)
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Rapamune (Sirolimus)
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Neoral / Sandimmune (Cyclosporine)
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Kidney Transplant Market Forecast, By Distribution Channel,2013 – 2017 and Forecast, 2018 – 2024
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Online Stores
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Kidney Transplant Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Region, 2018 – 2024
8. North America Kidney Transplant MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. Immunosuppressive/rejection Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Prograf (Tacrolimus)
8.1.2. Myfortic (Mycophenolic Acid)
8.1.3. Cellcept (Mycophenolate Mofetil)
8.1.4. Zortress / Certican (Everolimus)
8.1.5. Rapamune (Sirolimus)
8.1.6. Neoral / Sandimmune (Cyclosporine)
8.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Stores
8.3. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024
8.5. North America Kidney Transplant Market Dynamics – Trends
9. Europe Kidney Transplant Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Immunosuppressive/rejection Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prograf (Tacrolimus)
9.1.2. Myfortic (Mycophenolic Acid)
9.1.3. Cellcept (Mycophenolate Mofetil)
9.1.4. Zortress / Certican (Everolimus)
9.1.5. Rapamune (Sirolimus)
9.1.6. Neoral / Sandimmune (Cyclosporine)
9.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Stores
9.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024
9.5. Europe Kidney Transplant Market Dynamics – Trends
10. Asia-Pacific Kidney Transplant Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Immunosuppressive/rejection Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prograf (Tacrolimus)
10.1.2. Myfortic (Mycophenolic Acid)
10.1.3. Cellcept (Mycophenolate Mofetil)
10.1.4. Zortress / Certican (Everolimus)
10.1.5. Rapamune (Sirolimus)
10.1.6. Neoral / Sandimmune (Cyclosporine)
10.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Online Stores
10.3. Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024
10.5. Asia-Pacific Kidney Transplant Market Dynamics – Trends
11. Latin America Kidney Transplant Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Immunosuppressive/rejection Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prograf (Tacrolimus)
11.1.2. Myfortic (Mycophenolic Acid)
11.1.3. Cellcept (Mycophenolate Mofetil)
11.1.4. Zortress / Certican (Everolimus)
11.1.5. Rapamune (Sirolimus)
11.1.6. Neoral / Sandimmune (Cyclosporine)
11.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospital Pharmacies
11.2.2. Retail Pharmacies
11.2.3. Online Stores
11.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024
11.5. Latin America Kidney Transplant Market Dynamics – Trends
12. Middle East and Africa Kidney Transplant Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Immunosuppressive/rejection Drugs Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prograf (Tacrolimus)
12.1.2. Myfortic (Mycophenolic Acid)
12.1.3. Cellcept (Mycophenolate Mofetil)
12.1.4. Zortress / Certican (Everolimus)
12.1.5. Rapamune (Sirolimus)
12.1.6. Neoral / Sandimmune (Cyclosporine)
12.2. Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.2.3. Online Stores
12.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Kidney Transplant Market – Opportunity Analysis Index, By Immunosuppressive/rejection Drugs, By Distribution Channel and Country, 2018 – 2024
12.5. MEA Kidney Transplant Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Immunosuppressive/rejection Drugs& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Veloxis Pharmaceuticals A/S (Denmark)
13.2.2. Sanofi (France)
13.2.3. Immucor, Inc. (U.S)
13.2.4. Biocon Ltd. (India)
13.2.5. Novartis AG (Switzerland)
13.2.6. Pfizer, Inc. (U.S.)
13.2.7. Astellas Pharma (U.S.)
13.2.8. Hoffmann La Roche Ltd. (Switzerland)
14. Research Methodology
15. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Ask An Analyst

 

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials

Contact SalesTOLL FREE: +1-866-598-1553